| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $136K | -28.8% | -95.8% |
| SG&A Expense | $1.7M | +5.7% | +20.7% |
| Operating Income | -$7.8M | +4.9% | +48.0% |
| Net Income | -$6.6M | +19.2% | +53.3% |
| EPS (Basic) | -$0.33 | +29.3% | +66.6% |
| EPS (Diluted) | -$0.33 | +29.3% | +66.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $83.4M | +110.8% | +40.3% |
| Current Assets | $106.4M | +128.9% | +58.0% |
| Total Assets | $600.6M | +24.0% | +65.5% |
| Current Liabilities | $53.0M | +5.2% | +39.2% |
| Long-term Debt | $32.6M | — | — |
| Total Liabilities | $109.8M | +59.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.5M | -5.1% | — |
| Investing Cash Flow | -$66.5M | -134.0% | — |
| Financing Cash Flow | $133.5M | +251.9% | — |
| +103.8% |
| Stockholders' Equity | $358.9M | +21.6% | +47.1% |